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Abstract
Background:  A seventy nine year old lady presented with acute bilateral foot drop and
paraesthesia of her lower limbs as a presenting feature of Wegener's Granulomatosis (WG).
Case presentation: There was no evidence of pulmonary involvement and her renal function was
normal. WG can masquerade as very diverse pathology. It is recognised that neuropathy can occur
early and often in the absence of more classical pulmonary and renal findings, often resulting in a
delay in diagnosis.
Conclusion: Anti-neutrophil cytoplasmic antibody (ANCA) testing was particularly useful in this
case permitting early diagnosis.
Case presentation
A seventy nine year caucasian lady presented with bilat-
eral foot-drop and lower limb dysaesthesia. This was of
sudden onset. Left leg weakness and initial dysaesthesia of
the left foot, progressed over 48 hours to involve her right
leg. Apart from thoracic shingles nine months earlier and
pulmonary tuberculosis in her youth, she had no signifi-
cant past medical history. There were no upper or lower
respiratory symptoms and she denied any joint pain,
myalgia, sweats or haematuria. She was on no regular
medication, was a non smoker, and consumed only min-
imal alcohol. Family history was unremarkable and she
had no children.
On examination, there was a non-blanching erythema-
tous reticular rash on the anterior aspect of both calves.
She had bilateral foot-drop, with grade 0/5 power in all
foot movements. Knee jerks were brisk, but ankle jerks
were absent. She had bilaterally flexor plantar responses.
There was loss of pin-prick sensation to mid calf bilater-
ally. Joint position sense and vibration sense were absent
to below the knees. The remainder of the clinical exami-
nation was normal and she had a normal body mass
index.
A myelogram and cerebrospinal fluid analysis was nor-
mal. Neurophysiology demonstrated normal responses in
the arms but absent sensory and motor responses in both
legs, in keeping with severe bilateral lumbosacral plexop-
athy or length dependent neuropathy. An MRI scan of her
spine (to exclude a compressive lumbosacral polyradicu-
lopathy) showed only mild age related cerebral atrophy
and scattered degenerative changes. There was no evi-
dence of spinal cord or nerve root compromise. Chest x-
ray demonstrated evidence of old acid fast disease.
Laboratory results including full blood picture, urea and
electrolytes, fasting glucose, thyroid function tests, vita-
min B12, folate levels and rheumatoid factor were all nor-
mal. Liver function tests were abnormal with an ALP of
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515 U/l (35 – 120) and γ GT of 271 U/L (12 – 58). Hepa-
titis screening blood tests were normal and ultrasound
scanning of her abdomen showed several gallstones with
no evidence of biliary dilatation. She was treated empiri-
cally with intravenous methyl prednisolone (500 mg
daily) for presumed myelitis for 5 days prior to the results
of her MRI scan becoming available. Although she did not
improve clinically with this regime, there was a striking
fall in serum C reactive protein from an initial 118 mg/L
to 8.8 mg/L over this period. 10 days after stopping
methyl prednisolone, serum C reactive protein was 74.5
mg/L. Yet again this fell to 11.0 mg/L after 2 days resump-
tion of prednisolone and azathioprine (Fig 1). ANCA
results became available two days after admission. C-
ANCA was positive at 1:320 dilution, PR3-ANCA was pos-
itive 42.1 U/ml (< 2 U/ml). This led to a working diagno-
sis of WG. Nasal septum mucosal biopsy revealed non-
specific inflammation with no evidence of a vasculitic
process. The patient declined a nerve biopsy. Together
with a reducing course of steroids, she was commenced on
azathioprine 100 mg daily, twelve days after completing
the course of pulsed intravenous methylprednisolone.
12 months after the initiation of treatment she is clinically
well, with almost complete resolution of bilateral foot-
drop and no overt complications of treatment.
Discussion
WG, a triad of granulomatous lesions involving the upper
and lower airways, a systemic vasculitis and necrotising
crescentic vasculitis involving the kidney, was first
described in 1932 by Klinger et al [1]. Patients with WG
usually present with symptoms and signs of upper airway
or of lower airway disease. Less commonly patients
present solely with symptoms of renal disease. The diag-
nosis of WG rests on the recognition of typical clinical fea-
tures, supported wherever possible by confirmatory tissue
histology. The advent of anti-neutrophil cytoplasmic anti-
body (ANCA) testing in the last 20 years has provided a
valuable additional element in what can in certain cases
be a very difficult diagnosis. Despite advances in our
understanding of granuloma formation and improve-
ments in treatment the pathogenesis of WG remains
poorly understood. Treatment is based on combination
immunosuppressive regimes to induce remission fol-
lowed by lower dose maintenance therapy. Without treat-
ment, the prognosis is poor, with a median survival time
of four months [2]. With treatment, the chance of remis-
sion and long term survival is high with 7-year survival
figures of 58% for those patients over the age of 60 and a
corresponding value of 29% for those patients aged less
than 60 [3].
This case was a diagnostic dilemma because an elderly
female patient presented with peripheral neuropathy of
uncertain origin. A common cause was not identified, but
steroid therapy was commenced on an empirical basis.
There was no obvious clinical responses in terms of weak-
ness or sensation, however there was a dramatic response
in terms of the detectable acute phase response. Of itself
this suggested a steroid responsive inflammatory cause,
however it was the detection of high titre C-ANCA, con-
firmed by positive PR3-ANCA that indicated the underly-
ing diagnosis of WG. This provided justification for
recommencement of immunosuppressive therapy, which
continues.
Elderly people with WG present disproportionably with
CNS involvement (4.5 fold more commonly) and less
often with the classical symptoms [4]. Previous studies
have shown that this cohort of patients characteristically
present with symptoms and signs of pulmonary infiltrates
and renal impairment rather than features of upper airway
disease. This atypical presentation does not however
imply a more indolent course and elderly patients require
long term immunosuppressive treatment in the same way
as their younger counterparts. Accurate confirmation or
exclusion of the diagnosis of WG has enormous implica-
tions. An accurate and prompt diagnosis is potentially life
saving, but the inappropriate use of immunosuppressive
medication can have severe detrimental effects.
WG has been reported to present with diverse clinical
signs including ulceration of the breast, pleural effusion,
pituitary disease and as a Horners syndrome [5-8].
Although the detection of antineutrophil cytoplasmic
antibody (ANCA) can be useful in these particular cases
the results should be interpreted with caution. ANCA
detection should be used as an adjunct for establishing a
diagnosis of WG, but should not be used as a screening
test in unselected cases. A positive test in the context of
low pre-test probability may be a "false positive" result
and alternative diagnosis should be considered. On the
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other hand, a high titre ANCA in the context of high clin-
ical suspicion can enable the clinician to justify embark-
ing on aggressive immunosuppressive medications.
Clinical conditions recognised to cause "false positives"
include the connective tissue diseases, malignancy and
subclinical infections [9,10]. It is in the latter groups
where inadvertent use of immunosuppressant medica-
tions could have devastating consequences. Audit data
emphasises the caution required in interpretation of
ANCA results by showing that the positive predictive
value of ANCA of all types (including classical, perinu-
clear and intermediate staining patterns) was 27% in
unselected requests. This figure however rose to 75% if the
C-ANCA titre was particularly high (> 1:640) [9,10]. The
further work of Rao et al confirmed and extended this
observation that a positive ANCA in the context of a low
pre-test probability of systemic vasculitis is likely to be a
false positive result [11]. International guidelines for
ANCA testing were developed (table 1) [12].
In this case, ANCA testing was used appropriately, in line
with these international consensus guidelines and proved
useful in establishing a diagnosis. It is important to
emphasise that ANCA testing should only be requested in
these defined clinical situations and not be used as a
screening test for vasculitis in patients with non-specific
presentations [10].
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Table 1: Indications for ANCA testing [12]
Glomerulonephritis, especially rapidly progressive glomerulonephritis
Pulmonary haemhorrhage, especially pulmonary renal syndrome
Cutaneous vasculitis with systemic features
Multiple lung nodules
Chronic destructive disease of the upper airways
Long standing sinusitis or otitis
Subglottic tracheal stenosis
Mononeuritis multiplex or other peripheral neuropathy
Retro-orbital mass